Enhancing Alcoholism Pharmacotherapy Research via Behavioral Economics

通过行为经济学加强酒精中毒药物治疗研究

• 批准号: 7866056
• 负责人: JAMES MACKILLOP
• 金额: $ 4.65万
• 依托单位: UNIVERSITY OF GEORGIA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-15 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7866056
• 关键词: Alcohol consumption; Alcohol dependence; Alcoholism; Alcohols; Area; Attenuated; Award; Basic Science; Behavioral; Blood; Clinical; Clinical Data; Clinical Research; Clinical Trials; Data; Development; Doctor of Philosophy; Economics; Empirical Research; Fostering; Funding; Future; Individual; Intervention; Laboratories; Limb structure; Measures; Mediating; Mediator of activation protein; Mentors; Mentorship; Methods; Neurosciences; Pharmaceutical Preparations; Pharmacotherapy; Placebos; Principal Investigator; Psychopharmacology; Public Health; Recruitment Activity; Research; Research Project Grants; Research Training; Sedation procedure; Self Administration; Training; Translations; alcohol craving; alcoholism pharmacotherapy; attenuation; base; career; career development; craving; design; improved; novel; patient oriented research; pre-clinical research; programs; responsible research conduct; sobriety; topiramate

DESCRIPTION (provided by applicant): This proposal for a K23 Mentored Patient-Oriented Research Career Award is to provide James MacKillop, PhD, with the necessary mentorship and training to conduct high-quality research using behavioral economics to enhance research on pharmacotherapies for alcoholism. A behavioral economic approach may enhance pharmacotherapy research by focusing on medication effects on alcohol self-administration, facilitating mechanistic analyses, and providing greater translational consilience. The Career Development/Training Plan includes training in: 1) neuroscience and psychopharmacology; 2) laboratory methods for alcoholism pharmacotherapy research; 3) clinical methods for alcoholism pharmacotherapy research; 4) advanced training in behavioral economics; 5) professional development; 6) responsible conduct of research. The training will be overseen by a mentorship team comprised of Robert Swift, MD, PhD (Sponsor), Peter Monti, PhD (Co-Sponsor), Jennifer Tidey, PhD (Advisor), and Robert Miranda, Jr., PhD (Advisor). The training plan also proposes an empirical research project using behavioral economics to examine the effects of topiramate (TOP), a promising novel pharmacotherapy. The proposed study will recruit 60 alcohol dependent individuals who are not seeking treatment and study the effects of TOP under neutral conditions and during the ascending limb of the blood alcohol curve, using a 2 (TOP SOOmg/placebo) X 2 (neutral/ascending limb) mixed design. Based on its putative neuropharmacological actions and correlational clinical data, TOP is predicted to reduce alcohol self-administration on two behavioral economic measures. For exploratory purposes, the effects of TOP will also be examined during the descending limb of the blood alcohol curve. In addition to serving as criticial training; this research may have important clinical and methodological implications. RELEVANCE OF THE RESEARCH TO PUBLIC HEALTH: Medications for treating alcoholism have considerable promise and behavioral economics may enhance research in this area. This proposal is an application for a K23 Mentored Patient-Oriented Research Career Award for Dr. James MacKillop to gain the expertise to pursue this prospect, including mentorship, training, and an empirical study using behavioral economics to study topiramate, a promising new medication for alcoholism.

描述（由申请人提供）：K23指导的以患者为导向的研究职业奖的提案是为James MacKillop博士提供必要的指导和培训，利用行为经济学进行高质量的研究，以加强对酒精中毒药物疗法的研究。行为经济学方法可以通过关注药物对酒精自我管理的影响，促进机制分析，并提供更大的翻译一致性来加强药物治疗研究。职业发展/培训计划包括以下方面的培训：1）神经科学和精神药理学; 2）酒精中毒药物治疗研究的实验室方法; 3）酒精中毒药物治疗研究的临床方法; 4）行为经济学的高级培训; 5）专业发展; 6）负责任的研究行为。培训将由一个导师团队监督，该团队由Robert Swift，MD，PhD（赞助商），Peter Monti，PhD（联合赞助商），Jennifer Tidey，PhD（顾问）和Robert米兰达，Jr.组成，博士（顾问）。培训计划还提出了一个使用行为经济学的实证研究项目，以检查托吡酯（TOP），一种有前途的新药物治疗的效果。这项拟议的研究将招募60名不寻求治疗的酒精依赖者，并研究TOP的影响。 中性条件和血液酒精曲线上升段期间，使用2（TOP 500 mg/安慰剂）× 2（中性/上升段）混合设计。 基于其假定的神经药理学作用和相关的临床数据，TOP预计将减少酒精自我管理的两个行为经济措施。出于探索性目的，还将在血液酒精曲线的下降段检查TOP的影响。除了作为批判性训练，这项研究可能具有重要的临床和方法学意义。研究与公共卫生的相关性：治疗酒精中毒的药物有相当大的前景，行为经济学可能会加强这一领域的研究。该提案是为James MacKillop博士申请K23指导的以患者为导向的研究职业奖，以获得追求这一前景的专业知识，包括指导，培训和使用行为经济学研究托吡酯的实证研究，托吡酯是一种有前途的治疗酗酒的新药。